Caris Life Sciences shared a post on X:
”Join the Caris MI Clarity webinar with George Sledge, Chief Medical Officer at Caris Life Sciences.
Learn how this multimodal prognostic test provides early and late distant recurrence risk at diagnosis without genomic sequencing. Learn more about this approach and the MI Clarity Early Access Program.
Other Articles About Caris Life Sciences on OncoDaily.